|
FN3KRP expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.216800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.524570E-01 |
| Normal-vs-Stage2 |
3.359900E-02 |
| Normal-vs-Stage3 |
3.218000E-02 |
| Normal-vs-Stage4 |
6.480000E-03 |
| Stage1-vs-Stage2 |
7.561100E-04 |
| Stage1-vs-Stage3 |
2.823300E-04 |
| Stage1-vs-Stage4 |
8.21090000000524E-05 |
| Stage2-vs-Stage3 |
8.961000E-01 |
| Stage2-vs-Stage4 |
6.244800E-01 |
| Stage3-vs-Stage4 |
4.976400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.883400E-01 |
| Normal-vs-AfricanAmerican |
8.305000E-01 |
| Normal-vs-Asian |
7.510400E-01 |
| Caucasian-vs-AfricanAmerican |
7.299600E-01 |
| Caucasian-vs-Asian |
5.220400E-01 |
| AfricanAmerican-vs-Asian |
6.215600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.036300E-02 |
| Normal-vs-Female |
7.340300E-02 |
| Male-vs-Female |
1.28210000005513E-06 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.567000E-01 |
| Normal-vs-Age(41-60Yrs) |
9.893400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.562970E-01 |
| Normal-vs-Age(81-100Yrs) |
5.374800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.525000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.939400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.029000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.139650E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.945200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.373600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.39539999999217E-05 |
| Normal-vs-Grade 2 |
1.804190E-01 |
| Normal-vs-Grade 3 |
3.567600E-02 |
| Normal-vs-Grade 4 |
7.831000E-04 |
| Grade 1-vs-Grade 2 |
9.879100E-03 |
| Grade 1-vs-Grade 3 |
2.46039999999281E-05 |
| Grade 1-vs-Grade 4 |
7.87359999976367E-07 |
| Grade 2-vs-Grade 3 |
1.589070E-04 |
| Grade 2-vs-Grade 4 |
1.64653999999986E-05 |
| Grade 3-vs-Grade 4 |
6.956000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.157190E-03 |
| Normal-vs-ccB subtype |
5.9065999999941E-05 |
| ccA subtype-vs-ccB subtype |
4.77395900588817E-15 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.724200E-01 |
| Normal-vs-N1 |
8.655400E-03 |
| N0-vs-N1 |
1.410970E-01 |
|
|
